The US Food and Drug Administration (FDA) has announced new restrictions concerning the marketing of tobacco products such as e-cigarettes and vape pens in an effort to mitigate risks to public health.
Tobacco companies are using social media platforms like Instagram and Twitter to promote e-cigs and other vape products to children as young as 13.
The FDA recently went after VIVUS, a pharmaceutical company, for making false health claims about its product. Inappropriate drug promotions can pose serious issues for pharmaceutical companies that go beyond superficial penalties--companies can...